Treatment and outcome patterns in patients with Waldenström’s Macroglobulinemia (WM): An observational, retrospective chart review across Germany

• Conditions: C88.0; Waldenström macroglobulinaemia

• Registration Number: DRKS00027501
• Lead Sponsor: niversitätsklinikum Ulm

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-29
• Study Completion: 2022-09-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

All patients under or after treatment with a confirmed diagnosis of Waldenström’s macroglobulinaemia according to Onkopedia guidelines on WM will be included. The diagnosis should be confirmed according to guidelines valid at that time as well as risk stratification according to the International Prognostic Scoring System for WM Inclusion should be available.

Exclusion Criteria

Watch and wait patients as well as patients treated within clinical trials will not be included.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The aim of this study is to use retrospective observations of patient charts for a multicomparative analysis of different treatment lines and outcome patterns for patients with WM.

Secondary Outcome Measures

Name	Time	Method
Patient Characteristica<br>Diagnostic